Who will steer the World Health Organization through its next chapter? Explore Health Policy Watch’s daily series examining the platforms, records, and institutional hurdles facing each contender for WHO Director-General, continuing today with Budi Gunadi Sadikin. Access all candidate profiles on our dedicated election site. Indonesia’s nomination of its Health Minister, Budi Gunadi Sadikin, for […] Continue reading ->
Speaking at a flagship World Health Summit panel global health officials and pharmaceutical executives urged governments to reframe pandemic preparedness as ‘biodefence’ – a core national security asset and not a discretionary health expenditure. BERLIN – That strategic pivot is becoming urgent as both global health and aid budgets shrink and multilateral diplomacy on pandemic […] Continue reading ->
A new modelling study suggests that US Medicare “Most-Favored-Nation” policies on drug prices would cut Medicare spending on brand-name drugs, but potentially incentivize companies to increase prices or delay new drug launches elsewhere. Efforts to control the cost of government spending on drugs culminated in a Most-Favored-Nation (MFN) policy, a Trump administration initiative which ties […] Continue reading ->
After months of speculation, prospective candidates in the race to become the next Director-General of the World Health Organization (WHO) are now emerging. At the same time, member states have launched a process to review the global health architecture, with the aim of clarifying roles, strengthening coordination, and aligning financing more closely with national, regional, […] Continue reading ->
Luis Pizarro, Unitaid’s newly-appointed Executive Director comes to the organization with sizeable depth and breadth of experience – as the leader of Geneva’s Drugs for Neglected Diseases Initiative (DNDi) and before that, leadership of ventures in Africa, Asia and the Americas. However, his main challenge at Unitaid will be steadying the financially troubled organization, which […] Continue reading ->
Unitaid is quietly searching for its next leader behind closed doors amidst growing demands for transparency. Whoever takes the helm of the market-shaping agency will inherit an organisation that faces acute financial shortfalls and mounting pressure for institutional reform. As Unitaid celebrates its 20th anniversary, severe cuts to the agency’s funding threaten to disrupt the […] Continue reading ->
As artificial intelligence drives rapid health innovations, global guardrails, equitable data, and local capacity are needed to ensure equitable progress. To address this, a landmark framework launched by three United Nations agencies lays out a strategic roadmap for innovators. Meanwhile, health leaders emphasise that lower-income regions must become co-creators of future innovations. New guidelines for […] Continue reading ->
HPV vaccines have transformed cervical cancer prevention, but the next generation of vaccines must better reflect regional disease patterns, including the HPV35 genotype prevalent in Africa.   The recent WHO Global Status Report on Cancer paints a sobering picture. Among the many challenges, human papillomavirus, or HPV, is one of the world’s most serious infectious causes of […] Continue reading ->